These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 18311780)
1. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies. Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780 [TBL] [Abstract][Full Text] [Related]
2. Telomere length maintenance--an ALTernative mechanism. Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697 [TBL] [Abstract][Full Text] [Related]
3. Telomere maintenance by telomerase and by recombination can coexist in human cells. Cerone MA; Londono-Vallejo JA; Bacchetti S Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631 [TBL] [Abstract][Full Text] [Related]
4. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway. Grobelny JV; Kulp-McEliece M; Broccoli D Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632 [TBL] [Abstract][Full Text] [Related]
5. Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome. Jeyapalan JN; Varley H; Foxon JL; Pollock RE; Jeffreys AJ; Henson JD; Reddel RR; Royle NJ Hum Mol Genet; 2005 Jul; 14(13):1785-94. PubMed ID: 15888482 [TBL] [Abstract][Full Text] [Related]
6. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; Londoño-Vallejo A Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459 [TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms of telomere maintenance exist in liposarcomas. Johnson JE; Varkonyi RJ; Schwalm J; Cragle R; Klein-Szanto A; Patchefsky A; Cukierman E; von Mehren M; Broccoli D Clin Cancer Res; 2005 Aug; 11(15):5347-55. PubMed ID: 16061847 [TBL] [Abstract][Full Text] [Related]
8. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Jiang WQ; Zhong ZH; Henson JD; Reddel RR Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460 [TBL] [Abstract][Full Text] [Related]
9. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Yeager TR; Neumann AA; Englezou A; Huschtscha LI; Noble JR; Reddel RR Cancer Res; 1999 Sep; 59(17):4175-9. PubMed ID: 10485449 [TBL] [Abstract][Full Text] [Related]
10. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening. Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860 [TBL] [Abstract][Full Text] [Related]
11. Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres. Slatter T; Gifford-Garner J; Wiles A; Tan X; Chen YJ; MacFarlane M; Sullivan M; Royds J; Hung N Am J Pathol; 2010 Dec; 177(6):2694-700. PubMed ID: 21037079 [TBL] [Abstract][Full Text] [Related]
12. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles. Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069 [TBL] [Abstract][Full Text] [Related]
13. The role of recombination in telomere length maintenance. Royle NJ; Méndez-Bermúdez A; Gravani A; Novo C; Foxon J; Williams J; Cotton V; Hidalgo A Biochem Soc Trans; 2009 Jun; 37(Pt 3):589-95. PubMed ID: 19442255 [TBL] [Abstract][Full Text] [Related]
14. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549 [TBL] [Abstract][Full Text] [Related]
15. Alternative lengthening of telomeres in mammalian cells. Henson JD; Neumann AA; Yeager TR; Reddel RR Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785 [TBL] [Abstract][Full Text] [Related]
16. PML and TRF2 protein expression in hereditary and sporadic colon cancer. Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315 [TBL] [Abstract][Full Text] [Related]
17. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism. Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957 [TBL] [Abstract][Full Text] [Related]
18. ALT-associated promyelocytic leukaemia body (APB) detection as a reproducible tool to assess alternative lengthening of telomere stability in liposarcomas. Venturini L; Erdas R; Costa A; Gronchi A; Pilotti S; Zaffaroni N; Daidone M J Pathol; 2008 Mar; 214(4):410-4. PubMed ID: 18085522 [TBL] [Abstract][Full Text] [Related]
19. Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas. Lee JC; Jeng YM; Liau JY; Tsai JH; Hsu HH; Yang CY Mod Pathol; 2015 Aug; 28(8):1064-73. PubMed ID: 26022452 [TBL] [Abstract][Full Text] [Related]
20. Transient activation of the ALT pathway in human primary fibroblasts exposed to high-LET radiation. Berardinelli F; Antoccia A; Cherubini R; De Nadal V; Gerardi S; Cirrone GA; Tanzarella C; Sgura A Radiat Res; 2010 Nov; 174(5):539-49. PubMed ID: 20726710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]